The U.S. biomedical research enterprise has played a vital role in advancing science, human health, and the economy. It has contributed significantly to fields such as agriculture, environmental remediation, job creation, and technological innovation. Over the past 80 years, landmark achievements include reducing cancer mortality, developing HIV/AIDS treatments, sequencing the human genome, and creating vaccines that mitigated the impact of the COVID-19 pandemic. The enterprise has grown remarkably in less than a century and holds even greater potential for future success. However, its progress is hindered by a lack of high-level national coordination, a fragmented funding system, and a declining workforce.



The State of the U.S. Biomedical and Health Research Enterprise: Strategies for Achieving a Healthier America addresses these challenges in five key areas—strategic vision, funding, health equity, coordination and convergence science, and workforce development—offering a roadmap that could be used to sustain U.S. leadership in global health.

Table of Contents


Front Matter
Executive Summary
1 Introduction
2 A Strategic and Coordinated Approach to the U.S. Biomedical Research Enterprise
3 Streamlined, Coordinated, and Increasingly Impactful Funding
4 A Renewed Focus on Health Equity
5 The Need for Federal Coordination and Use of Convergence Science
6 A 21st-Century Workforce for the U.S. Biomedical Research Enterprise of the Future
7 A Renewed and Revitalized U.S. Biomedical Research Enterprise Is Possible
References